Prof Rainer Cramer FRSC is Professor of Mass Spectrometry and Bioanalytical Sciences at the University of Reading. He is an interdisciplinary scientist, who started his academic career as an experimental physicist and later moved on to cancer research and other research fields in the life sciences. Rainer has a strong background in biological mass spectrometry, proteomics and analytical chemistry. In general, his research interests are focused on the application of his physical science expertise to the analytical challenges posed by modern biosciences, including clinical research and diagnostics. He also has a strong interest in the fundamentals of mass spectrometry, particularly MALDI MS.
Hakim Djaballah CEO, Institute Pasteur - Korea
Dr. Djaballah has several years of industrial experience in early drug discovery gained over the years in pharma and biotech companies. He has extensive experiences in the areas of fluorescence technology, assay development, automation/robotics, HTS, compound & screening data management, software development & novel technologies. Dr Djaballah has been involved in developing and screening several targets in various therapeutic areas, including antibacterials, antivirals, antifungals, diabetes, CNS, cardiovascular, oncology & inflammation. He is currently the director of the high throughput drug screening core facility at Memorial Sloan Kettering Cancer Centre in New York. He obtained his BSc (Hons.) in biochemistry and biotechnology from the University of Birmingham, and his PhD in biochemistry from the University of Leicester, both in England.
Add to Calendar ▼2014-05-14 00:00:002014-05-15 00:00:00Europe/LondonAdvances in Automation and RoboticsAdvances in Automation and Robotics in Barcelona, SpainBarcelona, SpainSELECTBIOenquiries@selectbiosciences.com